Residents of Australia’s northern regions have sweltered as a heatwave has continued through the weekend, and is expected to ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

Respiratory illnesses like the flu and COVID-19 spread more commonly in the fall and winter months ahead, and doctors in ...

Pregnant women and babies will have greater protection against a condition known as respiratory syncytial virus as part of an ...

The Australian government has said it will make vaccination against respiratory syncytial virus (RSV) free for newborns and pregnant women starting in 2025. Mark Butler, the minister for health, on ...

The respiratory virus is the leading cause of hospitalisation for infants, with 12,000 babies admitted each year. Before next ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

The Royal Australian College of GPs (RACGP) has lauded the Federal Government's announcement of $174.5 million to provide free RSV vaccination during ...

The federal government will place RSV vaccines on the national immunisation program, as 12,000 babies are hospitalised with ...

Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...